The financing event was largely expected, not a surprise. Griffon closed the previously announced notes offering, so the main news is execution rather than a new strategic move. 〔0〕
| Financing item | Filing terms | Market read |
|---|---|---|
| Senior notes | $800M at 6.25%, due 2034 (Notes Offering) | Long-dated funding; approximately $792M net proceeds |
| Revolving facility | $500M, maturity extended to August 18, 2031 (Credit Agreement) | Capacity unchanged; five more years of availability |
| Capex covenant | Annual capital expenditures covenant eliminated (Credit Agreement) | More operating flexibility |
| Financial tests | Maximum leverage 5.50x; senior secured leverage 3.50x; interest coverage minimum 2.00x (Credit Agreement) | Core maintenance tests remain |
The clearest incremental benefit is flexibility, not more liquidity. The revolver remains $500 million, but its maturity moves to August 18, 2031, and the annual capital-expenditure covenant is removed. 〔1〕 That gives management more room to spend through the cycle without breaching a specific capex restriction, while the main leverage and interest-coverage tests remain in place.
The new notes lock in a sizable fixed-cost obligation. The company issued $800 million of 6.25% senior notes due 2034 and received approximately $792 million after fees and discounts. The filing does not disclose the debt being retired or the final change in total leverage, so it is not possible from this filing alone to conclude that balance-sheet leverage improved.
Net: modestly better financing terms versus the standing situation, but not a major surprise. The market already knew the offering was coming; the positive change is the longer revolver runway and looser capex restriction. Against that, Griffon still carries the 6.25% notes and retains meaningful leverage tests, making this a constructive refinancing rather than a fundamental balance-sheet reset.
Read the original 8-K on SEC EDGAR ↗